Menquadfi
Payments companies reported to CMS as associated with Menquadfi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Menquadfi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Menquadfi
These are the largest totals companies reported as associated with Menquadfi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marvin Bittner | Omaha, NE | Infectious Disease | $9,234.56 |
| Christopher Belcher | Carmel, IN | Pediatric Infectious Diseases | $4,521.00 |
| Jaime Fergie | Corpus Christi, TX | Pediatric Infectious Diseases | $4,005.00 |
| Mohammad Madjid | Ventura, CA | Interventional Cardiology | $2,909.00 |
| Audrey Stevenson | Phoenix, AZ | Family | $2,760.00 |
| Wendy Wright | Amherst, NH | Family | $2,416.00 |
| Martin Mahoney | Buffalo, NY | Family Medicine | $2,349.00 |
| Sharon Humiston | Kansas City, MO | Pediatrics | $2,136.00 |
| Vincent Hsu | Orlando, FL | Infectious Disease | $2,030.00 |
| Peter Sebeny | Newburyport, MA | Infectious Disease | $2,030.00 |
Prescribed Menquadfi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.